纵横研报
Ticker Detail

688426.SHG

¥17.42+2.29% 康为世纪 Biotechnology
00Reports China 医疗健康
Jiangsu Cowin Biotech Co. Ltd. A
医疗健康 · 生物科技

Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nucleic acid extraction and purification, marker clone transfection, antibody, protein detection products, and scientific research instruments. The company was founded in 2010 and is headquartered in Taizhou, China.

MARKET 市值 1.93B CNY 52W ¥15.83 – ¥33.67 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 37.2% ROE -7.4% 营业利润率 -32.0% 净利润率 -47.7%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制